AGIOS PHARMACEUTICALS, INC.00847X104US00847X104606/18/2026To vote, on an advisory basis, to approve the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER1185210FOR118521FOR CELLDEX THERAPEUTICS, INC.15117B202US15117B202506/25/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTESISSUER8797130FOR879713FOR CG ONCOLOGY, INC.156944100US156944100906/04/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER22214740FOR2221474FOR CG ONCOLOGY, INC.156944100US156944100906/04/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTESISSUER222147401 YEAR2221474FOR CORVUS PHARMACEUTICALS, INC.221015100US221015100506/11/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18312330FOR1831233FOR CRINETICS PHARMACEUTICALS, INC.22663K107US22663K107906/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;SECTION 14A SAY-ON-PAY VOTESISSUER2120100FOR212010FOR DENALI THERAPEUTICS INC.24823R105US24823R105906/03/2026Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER12099710FOR1209971FOR KYMERA THERAPEUTICS, INC.501575104US501575104406/24/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers; andSECTION 14A SAY-ON-PAY VOTESISSUER1463320FOR146332FOR MINERVA NEUROSCIENCES, INC.603380205US603380205806/03/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER19866000FOR1986600FOR MINERVA NEUROSCIENCES, INC.603380205US603380205806/03/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER198660001 YEAR1986600FOR VERASTEM, INC.92337C203US92337C203505/21/2026To approve an advisory vote on the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER31466310FOR3146631FOR